Efinaconazole: Difference between revisions

Efinaconazole
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Newer edit →

Revision as of 11:03, 15 February 2025

An antifungal medication used to treat onychomycosis

Efinaconazole is a topical antifungal medication primarily used for the treatment of onychomycosis, a fungal infection of the nails. It is marketed under the brand name Jublia, among others. Efinaconazole is notable for its ability to penetrate the nail plate and reach the site of infection effectively.

Mechanism of Action

Efinaconazole is an azole antifungal, which works by inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes. By disrupting the production of ergosterol, efinaconazole compromises the integrity of the fungal cell membrane, leading to cell death.

Clinical Use

Efinaconazole is specifically indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum and Trichophyton mentagrophytes. It is applied topically once daily to the affected toenail(s) for a duration of 48 weeks.

Pharmacokinetics

Efinaconazole is formulated as a 10% solution for topical application. The medication is designed to penetrate the nail plate and reach the nail bed, where the fungal infection resides. Systemic absorption is minimal, which reduces the risk of systemic side effects.

Side Effects

Common side effects of efinaconazole include application site reactions such as dermatitis, pruritus, and erythema. These side effects are generally mild and resolve without the need for discontinuation of therapy.

Advantages

Efinaconazole offers several advantages over other topical antifungal treatments, including its ability to penetrate the nail plate without the need for debridement or removal of the nail. This makes it a convenient option for patients who prefer non-invasive treatment methods.

Related pages

@@ Line 1: / Line 1: @@
-'''Efinaconazole''' is a triazole antifungal medication primarily used in the treatment of nail infections caused by [[fungi]], specifically for the treatment of [[onychomycosis]], a fungal infection that affects the toenails or fingernails. Efinaconazole acts by inhibiting the synthesis of [[ergosterol]], a critical component of fungal cell membranes, thereby exerting its antifungal effects and leading to the death of the fungal cells.
+{{Short description|An antifungal medication used to treat onychomycosis}}
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 477002123
+| image = Efinaconazole.svg
+| image2 = <!-- Another image if available -->
+}}
-==Medical Uses==
+'''Efinaconazole''' is a topical [[antifungal]] medication primarily used for the treatment of [[onychomycosis]], a fungal infection of the [[nail (anatomy)|nails]]. It is marketed under the brand name Jublia, among others. Efinaconazole is notable for its ability to penetrate the nail plate and reach the site of infection effectively.
-Efinaconazole is indicated for the topical treatment of onychomycosis of the toenails or fingernails due to dermatophytes ([[Trichophyton rubrum]] and [[Trichophyton mentagrophytes]]) and/or [[yeast]] ([[Candida]] species). Its formulation as a 10% topical solution is designed to penetrate the hard keratin of the nail, reaching the site of infection and providing effective antifungal activity.
-==Pharmacology==
+==Mechanism of Action==
-===Mechanism of Action===
+Efinaconazole is an [[azole antifungal]], which works by inhibiting the synthesis of [[ergosterol]], a critical component of fungal cell membranes. By disrupting the production of ergosterol, efinaconazole compromises the integrity of the fungal cell membrane, leading to cell death.
-Efinaconazole inhibits the synthesis of ergosterol by inhibiting fungal [[enzyme]]s, specifically [[14α-demethylase]]. This enzyme is involved in the conversion of lanosterol to ergosterol, an essential component of the fungal cell membrane. The inhibition of ergosterol synthesis leads to an accumulation of toxic intermediate products in the cell membrane and results in increased membrane permeability and ultimately, the death of the fungal cell.
-===Pharmacokinetics===
+==Clinical Use==
-The pharmacokinetic profile of efinaconazole shows that when applied topically, systemic absorption is minimal. This characteristic minimizes systemic side effects and makes efinaconazole a safe option for the treatment of onychomycosis. The drug is primarily metabolized in the liver and excreted in the feces.
+Efinaconazole is specifically indicated for the treatment of [[onychomycosis]] of the toenails due to [[Trichophyton rubrum]] and [[Trichophyton mentagrophytes]]. It is applied topically once daily to the affected toenail(s) for a duration of 48 weeks.
-==Adverse Effects==
+==Pharmacokinetics==
-The most common adverse effects associated with efinaconazole are local reactions at the application site, such as [[dermatitis]], [[erythema]], [[irritation]], and [[pain]]. These reactions are generally mild and transient. Systemic side effects are rare due to minimal systemic absorption.
+Efinaconazole is formulated as a 10% solution for topical application. The medication is designed to penetrate the nail plate and reach the nail bed, where the fungal infection resides. Systemic absorption is minimal, which reduces the risk of systemic side effects.
-==Contraindications==
+==Side Effects==
-Efinaconazole is contraindicated in patients with known hypersensitivity to efinaconazole or any of the excipients in the formulation. Caution is advised when prescribing to pregnant or breastfeeding women due to the lack of sufficient safety data.
+Common side effects of efinaconazole include application site reactions such as [[dermatitis]], [[pruritus]], and [[erythema]]. These side effects are generally mild and resolve without the need for discontinuation of therapy.
-==Interactions==
+==Advantages==
-Given its minimal systemic absorption, efinaconazole has a low potential for drug-drug interactions. However, patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and herbal supplements, to assess for potential interactions.
+Efinaconazole offers several advantages over other topical antifungal treatments, including its ability to penetrate the nail plate without the need for debridement or removal of the nail. This makes it a convenient option for patients who prefer non-invasive treatment methods.
-==Administration and Dosage==
+==Related pages==
-Efinaconazole is applied topically to the affected nail(s) once daily. The treatment duration is typically 48 weeks, but the duration may vary based on the severity of the infection and the clinical response. It is important to follow the application instructions carefully to ensure the medication reaches the site of infection effectively.
+* [[Onychomycosis]]
+* [[Antifungal]]
+* [[Azole]]
-==Conclusion==
+[[Category:Antifungal agents]]
-Efinaconazole is an effective and safe option for the topical treatment of onychomycosis. Its mechanism of action, targeting the synthesis of ergosterol, makes it a potent antifungal agent against the fungi responsible for nail infections. While efinaconazole is generally well-tolerated, patients should be aware of potential local adverse effects and follow their healthcare provider's instructions for use.
+[[Category:Dermatologic drugs]]
-[[Category:Antifungals]]
-[[Category:Triazoles]]
-{{Pharmacology-stub}}
-{{Medicine-stub}}